Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Boston Properties
BXP
$10.8B
| $223K | ﹤0.01% |
3,365
-269,188
| -99% | -$16.1M |
|
2702
Genco Shipping & Trading
GNK
$1.16B
| $222K | ﹤0.01% |
8,964
-2,900
| -24% | -$70K |
|
|
CMBT
2703
CMB.TECH NV
CMBT
$5.24B
| $221K | ﹤0.01% |
+15,797
| New | +$228K |
|
2704
Carpenter Technology
CRS
$24.4B
| $220K | ﹤0.01% |
357
-90,952
| -100% | -$42.8M |
|
2705
Gray Television
GTN
$509M
| $220K | ﹤0.01% |
55,467
-488,482
| -90% | -$2.25M |
|
2706
Federal Realty Investment Trust
FRT
$10.1B
| $220K | ﹤0.01% |
+1,783
| New | +$207K |
|
2707
iShares S&P Small-Cap 600 Value ETF
IJS
$8.33B
| $219K | ﹤0.01% |
+1,600
| New | +$206K |
|
|
PAYP
2708
PayPay
PAYP
$10.4B
| $218K | ﹤0.01% |
15,221
-308,044
| -95% | -$5.67M |
|
2709
Enphase Energy
ENPH
$5.1B
| $218K | ﹤0.01% |
4,421
-475,569
| -99% | -$21.7M |
|
2710
Enanta Pharmaceuticals
ENTA
$392M
| $217K | ﹤0.01% |
+14,915
| New | +$200K |
|
2711
Amerant Bancorp
AMTB
$1.12B
| $217K | ﹤0.01% |
8,488
-2,433
| -22% | -$56.6K |
|
2712
Hayward Holdings
HAYW
$3.09B
| $215K | ﹤0.01% |
+12,428
| New | +$181K |
|
|
HAPN
2713
Happen Inc
HAPN
$2.13B
| $215K | ﹤0.01% |
10,363
-19,759
| -66% | -$336K |
|
2714
Omnicell
OMCL
$1.62B
| $215K | ﹤0.01% |
5,175
-1,264
| -20% | -$51K |
|
2715
Privia Health
PRVA
$2.7B
| $214K | ﹤0.01% |
+8,311
| New | +$193K |
|
2716
Legacy Housing
LEGH
$681M
| $213K | ﹤0.01% |
+8,109
| New | +$185K |
|
2717
CALL
Bitdeer Technologies
BTDR
$3.09B
| $213K | ﹤0.01% |
+13,400
| New | +$192K |
|
2718
Weibo
WB
$1.73B
| $212K | ﹤0.01% |
29,235
+9,465
| +48% | +$77.3K |
|
2719
iShares Core S&P Total US Stock Market ETF
ITOT
$96.9B
| $212K | ﹤0.01% |
+1,291
| New | +$205K |
|
|
KREF
2720
KKR Real Estate Finance Trust
KREF
$487M
| $211K | ﹤0.01% |
30,828
-245,663
| -89% | -$1.63M |
|
2721
Myriad Genetics
MYGN
$306M
| $210K | ﹤0.01% |
+36,860
| New | +$167K |
|
2722
Rush Enterprises Class B
RUSHB
$8.58B
| $210K | ﹤0.01% |
+2,748
| New | +$192K |
|
2723
Perdoceo Education
PRDO
$2.07B
| $209K | ﹤0.01% |
6,530
-1,159
| -15% | -$39.7K |
|
|
CEPF
2724
Cantor Equity Partners IV
CEPF
$591M
| $208K | ﹤0.01% |
20,000
| – | – |
|
|
UMH
2725
UMH Properties
UMH
$1.41B
| $207K | ﹤0.01% |
13,681
-27,725
| -67% | -$424K |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.